Archives of Clinical Infectious Diseases

Published by: Kowsar

Otomycosis in Western Iran: Clinical and Mycological Aspects

Sajad Cheraghsahar 1 , Siros Kazemi 2 , Mehdi Birjandi 3 , Mohammad Yarahmadi 4 , 5 , Shahram Mahmoudi 4 , 6 , Rasoul Mohammadi 7 and Asghar Sepahvand 5 , *
Authors Information
1 Students Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
2 Department of ENT, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Department of Biostatistics, Lorestan University of Medical Sciences, Khorramabad, Iran
4 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5 Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
6 Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
7 Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2017, 12 (2); e57287
  • Published Online: April 30, 2017
  • Article Type: Research Article
  • Received: August 19, 2016
  • Revised: January 5, 2017
  • Accepted: February 5, 2017
  • DOI: 10.5812/archcid.57287

To Cite: Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, et al. Otomycosis in Western Iran: Clinical and Mycological Aspects, Arch Clin Infect Dis. 2017 ; 12(2):e57287. doi: 10.5812/archcid.57287.

Abstract
Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Nemati S, Hassanzadeh R, Khajeh Jahromi S, Delkhosh Nasrollah Abadi A. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014; 271(5): 953-7[DOI][PubMed]
  • 2. Saki N, Rafiei A, Nikakhlagh S, Amirrajab N, Saki S. Prevalence of otomycosis in Khouzestan Province, south-west Iran. J Laryngol Otol. 2013; 127(1): 25-7[DOI][PubMed]
  • 3. Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia. 2015; 179(5-6): 415-24[DOI][PubMed]
  • 4. Barati B, Okhovvat SA, Goljanian A, Omrani MR. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011; 13(12): 873-6[PubMed]
  • 5. Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012; 55(5): 404-9[DOI][PubMed]
  • 6. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008; 51(1): 67-70[DOI][PubMed]
  • 7. Vennewald I, Klemm E. Otomycosis: Diagnosis and treatment. Clin Dermatol. 2010; 28(2): 202-11[DOI][PubMed]
  • 8. Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol. 2006; 1(4): 141-4
  • 9. Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003; 112(4): 384-7[DOI][PubMed]
  • 10. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135(5): 787-91[DOI][PubMed]
  • 11. Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol. 2015; 8(9)[DOI][PubMed]
  • 12. Desai KJ, Malek SS, Italia IK, Jha S, Pandya V, Shah H. Fungal spectrum in otomycosis at tertiary care hospital. Natl J Integr Res Med. 2012; 3(5)
  • 13. Song JE, Haberkamp TJ, Patel R, Redleaf MI. Fungal otitis externa as a cause of tympanic membrane perforation: a case series. Ear Nose Throat J. 2014; 93(8): 332-6[PubMed]
  • 14. Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol. 2015; 8(5)[DOI][PubMed]
  • 15. Nowrozi H, Doustdar Arabi F, Ghaffarnejad Mehraban H, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014; 3(2): 29-31
  • 16. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008; 72(4): 453-9[DOI][PubMed]
  • 17. Abdelazeem M, Gamea A, Mubarak H, Elzawawy N. Epidemiology, causative agents, and risk factors affecting human otomycosis infections. Turk J Med Sci. 2015; 45(4): 820-6[DOI][PubMed]
  • 18. Bhan C, Purohit K, Prasad Purohit J, Kumar V, Singh Yadav H. Clinical vs bacteriological and mycological evaluation in chronic suppurative otitis media. Int J Contemp Med Res. 2016; 3(5): 1443-7
  • 19. Pontes ZB, Silva AD, Lima Ede O, Guerra Mde H, Oliveira NM, Carvalho Mde F, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009; 75(3): 367-70[DOI][PubMed]
  • 20. Ibiam F, Adekwu A, Obasikene G, Ezeanolue B, Okoroafor I, Iroezindu M. Aetiological agents implicated in otitis externa-an update. PMJUMU. 2016; 5(9): 1-12
  • 21. Ozcan M, Ozcan KM, Karaarslan A, Karaarslan F. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol. 2003; 260(1): 24-7[DOI][PubMed]
  • 22. Arndal E, Glad H, Homoe P. Large discrepancies in otomycosis treatment in private ear, nose, and throat clinics in Denmark. Dan Med J. 2016; 63(5)[PubMed]
  • 23. Kurnatowski P, Filipiak J. Otitis externa: the analysis of relationship between particular signs/symptoms and species and genera of identified microorganisms. Wiad Parazytol. 2008; 54(1): 37-41[PubMed]
  • 24. Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. Ear Nose Throat J. 2008; 87(11): 622-3[PubMed]
  • 25. Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012; 55(4): 333-8[DOI][PubMed]
  • 26. Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007; 50(6): 447-50[DOI][PubMed]
  • 27. Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012; 174(2): 143-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments